Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...

Independent network The Bloc has appointed Jon Chapman as European Executive Creative Director. Chapman previously held ...

How do we translate individual experiences into support that helps others and create support that feels personal but remains ...

Camena Bioscience, a pioneer in enzymatic DNA synthesis producing complex, high-fidelity gene constructs for AI-driven ...

Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with ...

Independent healthcare communications consultancy POP Health has appointed Stephanie O’Hagan as Senior Director. O’Hagan has ...

New op-ed published by leaders from the Women’s Alzheimer’s Movement at Cleveland Clinic, Alzheimer’s Research UK and the ...